[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351930-105":59,"doc-detail-351930-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pan-cancer-investigation-identifies-arl4a-as-a-prospective-therapeutic-indicator-for-thyroid-cancer","Pan-cancer investigation identifies ARL4A as a prospective therapeutic indicator for thyroid cancer","","A study investigates ADP-ribosylation factor-like 4 A (ARL4A), a small GTPase implicated in cytoskeletal dynamics and signal transduction, where dysregulated expression is reported across cancers but its pan-cancer relevance and thyroid carcinoma (THCA) roles remain unclear. Multi-omics analyses across 33 tumor types were combined with functional THCA experiments. Findings evaluate expression, prognosis, genetic/epigenetic alterations, immune correlations, drug sensitivity, and effects on proliferation, migration, and EMT.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pan-cancer-investigation-identifies-arl4a-as-a-prospective-therapeutic-indicator-for-thyroid-cancer/351930/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pan-cancer-investigation-identifies-arl4a-as-a-prospective-therapeutic-indicator-for-thyroid-cancer/351930.png","ImageObject",300,407,{"name":92,"@type":93},"Mary Man","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research goal of the study?","Question",{"text":112,"@type":113},"To perform a systematic pan-cancer analysis of ARL4A and clarify its expression patterns, prognostic value, molecular alterations, immune correlations, drug sensitivity, and functional role in thyroid cancer progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which datasets and analytical tools were used to evaluate ARL4A across cancers?",{"text":117,"@type":113},"The analysis leveraged multi-omics data from TCGA and tools including TIMER2.0, GEPIA2, UALCAN, cBioPortal, and LinkedOmics.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional effects did ARL4A overexpression have in THCA cell lines?",{"text":121,"@type":113},"Overexpressing ARL4A in THCA cell lines enhanced proliferation and migration and increased epithelial-mesenchymal transition marker expression such as N-cadherin and Vimentin.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351930,1790341314,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},7421720224475,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Men et al. Discover Oncology (2026) 17:989 Discover Oncology  \n[https://doi.org/10.1007/s12672-026-05114-w](https://doi.org/10.1007/s12672-026-05114-w)  \nRESEARCH Open Access  \nPan-cancer investigation identifies ARL4A as a prospective therapeutic indicator for thyroid cancer  \nYingli Men1, Jizhi Zhao1, Ruiting Feng1, Zhaorui Wang1, Beibei Ye3, Yang Zheng4, Zhenzhen Yang1, Xu Chen1, Lu Zhang1, Nan Wang1, Yongfeng Chen5, Yi Shao6, Hui Wang1, Yinsen Song1* and Cong Ding2*  \n*Correspondence:  \nYinsen Song [df13607670608@163.com](df13607670608@163.com)[ ](df13607670608@163.com)Cong Ding [dingcong8866@163.com](dingcong8866@163.com)  \nFull list of author information is available at the end of the article  \nAbstract  \nBackground ADP-ribosylation factor-like 4 A (ARL4A), a small GTPase involved in cytoskeletal dynamics and signal transduction, exhibits dysregulated expression in various cancers, yet its comprehensive role across tumor types, particularly in thyroid carcinoma (THCA), remains underexplored. This study aimed to perform a systematic pan-cancer analysis of ARL4A to elucidate its expression patterns, prognostic implications, genetic and epigenetic alterations, immune correlations, drug sensitivity, and functional contributions toTHCA progression.  \nMethods Leveraging multi-omics data from TCGA and tools including TIMER2 . 0, GEPIA2, UALCAN, cBioPortal, and LinkedOmics, we evaluated ARL4A across 33 cancer types. Functional validation was conducted by overexpressing ARL4A in THCA cell lines (BCPAP and KTC-1), with assessments via Western blotting, CCK-8 proliferation assays, wound healing, and Transwell migration assays.  \nResults ARL4A mRNA levels were significantly reduced in tumors such as THCA, correlating with early stages in some cancers but poor overall survival in THCA, adrenocortical carcinoma, and bladder cancer. Genetic amplifications predominated, alongside promoter hypomethylation in multiple malignancies. ARL4A expression inversely correlated with CD8 + T cells and other antitumor infiltrates while positively associating with myeloid-derived suppressor cells and immunosuppressive chemokines. Drug sensitivity analysis revealed negative correlations with HSP90 inhibitors. In THCA cells, ARL4A overexpression enhanced proliferation, migration, and epithelial-mesenchymal transition markers (N-cadherin and Vimentin) .  \nConclusions These results establish ARL4A as an oncogenic promoter in THCA through modulation of proliferation, migration, and immunosuppressive microenvironments, positioning it as a promising prognostic biomarker and therapeutic target for precision oncology.  \nKeywords Pan-cancer, ARL4A, Thyroid cancer  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by-nc-nd/4.0/.  \n1 Introduction  \nCancer remains one of the leading causes of morbidity and mortality worldwide, with projections indicating over 2 million new cases in the United States alone in 2025 and a global rise to more than 35 million new cases by 20","cbCaiaRUqjhhULki","https://ap.wps.com/l/cbCaiaRUqjhhULki","pdf",3084089,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main research goal of the study?\",\"answer\":\"To perform a systematic pan-cancer analysis of ARL4A and clarify its expression patterns, prognostic value, molecular alterations, immune correlations, drug sensitivity, and functional role in thyroid cancer progression.\"},{\"question\":\"Which datasets and analytical tools were used to evaluate ARL4A across cancers?\",\"answer\":\"The analysis leveraged multi-omics data from TCGA and tools including TIMER2.0, GEPIA2, UALCAN, cBioPortal, and LinkedOmics.\"},{\"question\":\"What functional effects did ARL4A overexpression have in THCA cell lines?\",\"answer\":\"Overexpressing ARL4A in THCA cell lines enhanced proliferation and migration and increased epithelial-mesenchymal transition marker expression such as N-cadherin and Vimentin.\"}]","Pan-cancer investigation identifies ARL4A as a prospective therapeutic indicator for thyroid cancer | PDF",1790096531,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7eb7c444eb72bfe4e969af01e17c575d.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a628e1d9eeba68c935b1f018e139a119.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f01615c737c4176841258f346d93c1d1.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72c34ad61afcab9f69825c78291a8ce3.webp",980,1306]